CHICAGO (Reuters) - A new class of drugs used to treat cancer might be effective at suppressing overactive immune systems in patients with autoimmune diseases like Crohn’s disease, U.S. researchers said on Sunday."What we would be proposing would be a therapy that would enhance the body’s own immune system’s ability to regulate itself,” said Wayne Hancock of Children’s Hospital of Philadelphia, whose study appears in the journal Nature Medicine.
